Showing results (151-160 of 431) with videos related to

Sort By:
Pageof 44
International Journal of Clinical Oncology|October 12, 2012
Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairmentTomoko Ogawa, Seiji Niho, Shunji Nagai, et al.
JTO Clinical and Research Reports|November 24, 2025
Genetic Characteristics of Disease Flare After Lenvatinib Discontinuation in Patients With Thymic Carcinoma: A Brief ReportTomoaki Nakamura, Tatsuya Yoshida, Ken Masuda, et al.
NPJ Precision Oncology|January 15, 2025
Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Takaji Matsutani, et al.
JAMA Oncology|November 22, 2023
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical TrialYusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa, et al.
Clinical Lung Cancer|November 2, 2025
Genomic Profiles as Predictors of Occult Lymph Node Metastasis and Clinical Outcomes in Early-Stage Clinical N0 Non-Small Cell Lung CancerChihiro Takemura, Tatsuya Yoshida, Yukihiro Yoshida, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2020
Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patientsAki K Kobayashi, Hidehito Horinouchi, Yuko Nakayama, et al.
Cancer Science|September 6, 2007
Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lungTomoya Fukui, Koji Tsuta, Koh Furuta, et al.
Respiratory Investigation|December 2, 2022
Prognostic role of modified Glasgow Prognostic score in elderly non-small cell lung cancer patients treated with anti-PD-1 antibodiesTomohiro Tanaka, Tatsuya Yoshida, Ken Masuda, et al.
Cancer Science|October 22, 2009
Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancerKazuhiko Yamada, Masao Nakao, Chikara Fukuyama, et al.
Carcinogenesis|October 3, 2017
The genomic and epigenomic landscape in thymic carcinomaMotonobu Saito, Yutaka Fujiwara, Tetsuhiko Asao, et al.
Pageof 44